Articles
2 articles available
Hui Zhang
(Baker & McKenzie)
,
Richard Li
(Baker & McKenzie FenXun (FTZ))
,
Dani Min
,
Jiao Yuxin
(ZY Partners)
April 3, 2018
On October 8, 2017, the Chinese Communist Party and the State Council jointly issued a special opinion on the reform of drug and medical device approval system (“Innovation Opinion”). The Innovation…
February 10, 2017
A positive view is spreading on post-filing experimental data in China since the recent official post of the proposed revisions to the Guidelines for Patent Examination (the “Guidelines”) by the…